Shu‐Jyuan Chang

469 total citations
25 papers, 343 citations indexed

About

Shu‐Jyuan Chang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shu‐Jyuan Chang has authored 25 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Shu‐Jyuan Chang's work include Cancer, Hypoxia, and Metabolism (6 papers), Cell Adhesion Molecules Research (5 papers) and Epigenetics and DNA Methylation (4 papers). Shu‐Jyuan Chang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Cell Adhesion Molecules Research (5 papers) and Epigenetics and DNA Methylation (4 papers). Shu‐Jyuan Chang collaborates with scholars based in Taiwan, United States and China. Shu‐Jyuan Chang's co-authors include Chi‐Wen Luo, Ming‐Feng Hou, Mei‐Ren Pan, Chee‐Yin Chai, Chun‐Chieh Wu, Fu Ou‐Yang, Aij‐Lie Kwan, Anne Le, Hon‐Kan Yip and Chih‐Hung Lin and has published in prestigious journals such as International Journal of Molecular Sciences, Experimental Cell Research and Life Sciences.

In The Last Decade

Shu‐Jyuan Chang

23 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu‐Jyuan Chang Taiwan 12 204 124 95 51 49 25 343
Mattia Falcone Netherlands 9 220 1.1× 110 0.9× 85 0.9× 55 1.1× 51 1.0× 13 374
Chee Man Cheong Australia 8 259 1.3× 155 1.3× 98 1.0× 45 0.9× 26 0.5× 10 434
Qiu-Wan Wu China 11 308 1.5× 143 1.2× 206 2.2× 49 1.0× 26 0.5× 14 460
Daniel Delgado‐Bellido Spain 10 339 1.7× 175 1.4× 182 1.9× 56 1.1× 29 0.6× 18 488
Tian-Xia Jiang China 7 206 1.0× 60 0.5× 47 0.5× 48 0.9× 36 0.7× 10 289
Wei Zong China 7 328 1.6× 190 1.5× 94 1.0× 39 0.8× 25 0.5× 8 445
Sri HariKrishna Vellanki Ireland 9 274 1.3× 101 0.8× 64 0.7× 39 0.8× 23 0.5× 13 340
Hsiang-Hao Chuang Taiwan 10 247 1.2× 84 0.7× 51 0.5× 49 1.0× 47 1.0× 16 360
Julien H. Dey Switzerland 7 312 1.5× 124 1.0× 104 1.1× 40 0.8× 31 0.6× 7 446

Countries citing papers authored by Shu‐Jyuan Chang

Since Specialization
Citations

This map shows the geographic impact of Shu‐Jyuan Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Jyuan Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Jyuan Chang more than expected).

Fields of papers citing papers by Shu‐Jyuan Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Jyuan Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Jyuan Chang. The network helps show where Shu‐Jyuan Chang may publish in the future.

Co-authorship network of co-authors of Shu‐Jyuan Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Jyuan Chang. A scholar is included among the top collaborators of Shu‐Jyuan Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Jyuan Chang. Shu‐Jyuan Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Chi‐Wen, Shu‐Jyuan Chang, Wangta Liu, et al.. (2024). Targeting Bmi1 for Enhancing Anoikis Sensitivity and Inhibiting Metastasis in Colorectal Cancer. Cancer Genomics & Proteomics. 21(5). 523–532. 3 indexed citations
2.
Huang, Wei-Lun, Yin-Chou Hsu, Chi‐Wen Luo, et al.. (2024). Targeting the CDK7-MDK axis to suppresses irinotecan resistance in colorectal cancer. Life Sciences. 353. 122914–122914. 3 indexed citations
3.
Chang, Shu‐Jyuan, Wan‐Tzu Chen, & Chee‐Yin Chai. (2024). Arsenic-induced disruption of circadian rhythms and glutamine anaplerosis in human urothelial carcinoma. Journal of Trace Elements in Medicine and Biology. 86. 127507–127507.
4.
Chang, Shu‐Jyuan, et al.. (2023). An Optimized Melanin Depigmentation Method for Histopathological and Immunohistochemical Staining of Formalin-Fixed Paraffin-Embedded Tissues. International Journal of Surgical Pathology. 32(4). 679–683. 1 indexed citations
5.
Pan, Mei‐Ren, Jun‐Ping Shiau, Chun‐Chieh Wu, et al.. (2023). Combination of FAK inhibitor and cytokine-induced killer cell therapy: An alternative therapeutic strategy for patients with triple-negative breast cancer. Biomedicine & Pharmacotherapy. 163. 114732–114732. 10 indexed citations
6.
Chang, Shu‐Jyuan, et al.. (2023). Comparison of Confirmed Cytology Smears and Cell Blocks for Epidermal Growth Factor Receptor Mutation Testing in Non–Small Cell Lung Cancer. Applied immunohistochemistry & molecular morphology. 31(10). 701–706.
7.
Chang, Shu‐Jyuan, et al.. (2022). CHD4 plays a critical role in arsenite-induced oxidative damage in human urothelial carcinoma. Pathology - Research and Practice. 240. 154173–154173. 2 indexed citations
8.
Chang, Shu‐Jyuan, et al.. (2022). The Diagnostic Significance of CXCL13 in M2 Tumor Immune Microenvironment of Human Astrocytoma. Pathology & Oncology Research. 28. 1610230–1610230. 3 indexed citations
9.
Shiau, Jun‐Ping, Shu‐Jyuan Chang, Mei‐Ren Pan, et al.. (2021). FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer. Biomedicines. 9(12). 1789–1789. 35 indexed citations
10.
Chang, Shu‐Jyuan, et al.. (2021). Non-Hodgkin Lymphoma Metabolism. Advances in experimental medicine and biology. 103–116. 10 indexed citations
11.
Chang, Chia‐Lo, Chi‐Ruei Huang, Shu‐Jyuan Chang, et al.. (2021). CHD4 as an important mediator in regulating the malignant behaviors of colorectal cancer. International Journal of Biological Sciences. 17(7). 1660–1670. 14 indexed citations
12.
Wang, Hui‐Ching, Leong‐Perng Chan, Chun‐Chieh Wu, et al.. (2021). Silencing DNA Polymerase β Induces Aneuploidy as a Biomarker of Poor Prognosis in Oral Squamous Cell Cancer. International Journal of Molecular Sciences. 22(5). 2402–2402. 6 indexed citations
13.
Hsu, Yin-Chou, Chi‐Wen Luo, Wei‐Lun Huang, et al.. (2020). BMI1-KLF4 axis deficiency improves responses to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer. Radiotherapy and Oncology. 149. 249–258. 13 indexed citations
14.
Chang, Shu‐Jyuan, Hung‐Pin Tu, Chi‐Wen Luo, et al.. (2020). Increased Vascular Adhesion Protein 1 (VAP-1) Levels Are Associated with Alternative M2 Macrophage Activation and Poor Prognosis for Human Gliomas. Diagnostics. 10(5). 256–256. 19 indexed citations
15.
Pan, Mei‐Ren, Ming‐Feng Hou, Fu Ou‐Yang, et al.. (2019). FAK is Required for Tumor Metastasis-Related Fluid Microenvironment in Triple-Negative Breast Cancer. Journal of Clinical Medicine. 8(1). 38–38. 30 indexed citations
16.
Ou‐Yang, Fu, Mei‐Ren Pan, Shu‐Jyuan Chang, et al.. (2019). Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics. Life Sciences. 238. 116963–116963. 16 indexed citations
17.
Luo, Chi‐Wen, Chun‐Chieh Wu, Shu‐Jyuan Chang, et al.. (2018). CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells. Experimental Cell Research. 363(1). 65–72. 27 indexed citations
18.
Chang, Shu‐Jyuan, et al.. (2018). Non-Hodgkin Lymphoma Metabolism. Advances in experimental medicine and biology. 1063. 95–106. 20 indexed citations
19.
Chang, Shu‐Jyuan, Fu Ou‐Yang, Hung‐Pin Tu, et al.. (2015). Decreased expression of autophagy protein LC3 and stemness (CD44+/CD24−/low) indicate poor prognosis in triple-negative breast cancer. Human Pathology. 48. 48–55. 27 indexed citations
20.
Buzzanco, Anthony S., Angela C. Gomez, B.A. French, et al.. (2014). Digital quantitation of HCC-associated stem cell markers and protein quality control factors using tissue arrays of human liver sections. Experimental and Molecular Pathology. 97(3). 399–410. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mattia Falcone Breakdown of academic impact, for papers by Chee Man Cheong Breakdown of academic impact, for papers by Qiu-Wan Wu Breakdown of academic impact, for papers by Daniel Delgado‐Bellido Breakdown of academic impact, for papers by Tian-Xia Jiang Breakdown of academic impact, for papers by Wei Zong Breakdown of academic impact, for papers by Sri HariKrishna Vellanki Breakdown of academic impact, for papers by Hsiang-Hao Chuang Breakdown of academic impact, for papers by Julien H. Dey
Rankless by CCL
2026